BackgroundMidazolam is used for sedation before diagnostic and therapeutic medical procedures. It is an imidazole benzodiazepine that has depressant e ects on the central nervous system (CNS) with rapid onset of action and few adverse e ects. The drug can be administered by several routes including oral, intravenous, intranasal and intramuscular.
ObjectivesTo determine the evidence on the e ectiveness of midazolam for sedation when administered before a procedure (diagnostic or therapeutic).